JOHNSON & JOHNSON - 25 Nov 2025 Form 4/A - Amendment Insider Report for CVRx, Inc. (CVRX)

Reporting relationship: 10%+ Owner
Issuer ticker: CVRX
Reported as of: 25 Nov 2025
Net transaction value: -$224,040
SEC form: 4/A - Amendment
Accepted by SEC: 08 Jan 2026, 16:05:54 UTC
Original report date: 01 Dec 2025
Prior SEC filing: 25 Nov 2025
Next SEC filing: 01 Dec 2025
Source filing: View source filing
Reporting owner signature: Johnson & Johnson By /s/ Marc Larkins, Secretary

Key filing fact

JOHNSON & JOHNSON filed Form 4/A - Amendment for CVRx, Inc. (CVRX) on 08 Jan 2026.

Key facts

This page summarizes JOHNSON & JOHNSON's Form 4/A - Amendment filing for CVRx, Inc. (CVRX).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 08 Jan 2026, 16:05.

Change

Previous filing in this sequence was filed on 25 Nov 2025.
Current net transaction value: -$224,040.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (2)

CIK 0000200406 Primary reporting owner

JOHNSON & JOHNSON

Relationship: 10%+ Owner
Address: ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK
Signature: Johnson & Johnson By /s/ Marc Larkins, Secretary
Signature date: 08 Jan 2026

CIK 0000924020

Johnson & Johnson Innovation - JJDC, Inc.

Relationship: 10%+ Owner
Address: 410 GEORGE STREET, NEW BRUNSWICK
Signature: Johnson & Johnson Innovation - JJDC, Inc. By: /s/ Jill McManus, Assistant Treasurer
Signature date: 08 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CVRX transaction

Common Stock

Sale

Transaction value: $160,480
Shares: -16,000
Change %: -0.4%
Price: $10.03
Shares after: 4,031,198
Date: 25 Nov 2025
Ownership: By Johnson & Johnson Innovation - JJDC, Inc.
Footnotes: F1, F2

CVRX transaction

Common Stock

Sale

Transaction value: $63,560
Shares: -6,337
Change %: -0.16%
Price: $10.03
Shares after: 4,024,861
Date: 26 Nov 2025
Ownership: By Johnson & Johnson Innovation - JJDC, Inc.
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.00 to $10.22. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F2

The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. ("JJDC"). JJDC is a wholly-owned subsidiary of Johnson & Johnson.

Footnote F3

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.00 to $10.23. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC remarks

This Amendment to the Form 4 filed on 12/01/2025 is being filed to include the sale of shares on 11/25/2025, which was inadvertently omitted from the original filing due to an administrative oversight.